ZTST (ZTST) has had the highest return since January 1, 2025 by a US stock with an IPO date in 2015, returning 30,631.9%.
| ASSET | % RETURN |
|---|---|
ZTST (ZTST) | 30,631.89% |
Cidara Therapeutics (CDTX) | 233.81% |
CytomX Therapeutics (CTMX) | 187.13% |
SolarEdge Technologies (SEDG) | 181.38% |
Mercurity Fintech Holding Inc ADR (MFH) | 172.71% |
GD Culture (GDC) | 154.01% |
Check-Cap (CHEK) | 127.84% |
Lumentum (LITE) | 91.01% |
Sunrun (RUN) | 86.2% |
Rimini Street (RMNI) | 79.18% |
Babcock & Wilcox Enterprises (BW) | 69.41% |
Verb Technology (VERB) | 65.63% |
vTv Therapeutics (VTVT) | 62.87% |
Kenon (KEN) | 50.04% |
Baozun (BZUN) | 48.18% |
Kalvista Pharmaceuticals (KALV) | 44.19% |
Avalo Therapeutics (AVTX) | 44% |
Creative Medical Technology (CELZ) | 43.07% |
Skye Bioscience, Inc Common Stock (SKYE) | 41.24% |
Ascendis Pharma A-S (ASND) | 39.36% |
Axsome Therapeutics (AXSM) | 36.96% |
Edesa Biotech (EDSA) | 36.07% |
Arbutus Biopharma (ABUS) | 33.64% |
Pure Storage (PSTG) | 33.16% |
Liberty Latin America Ltd Class C (LILAK) | 31.92% |
